Sumey, Christopher
16Sanford Cancer Center, Sioux Falls, South Dakota.
3 papers on CoChatORCID 0000-0002-9288-2236
Most cited papers
- Verified
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Paz-Ares, L., Dvorkin, M., Chen, Y., Reinmuth, N., Hotta, K., Trukhin, D., Statsenko, G., Hochmair, M. J., Özgüroğlu, M., Ji, J. H., et al. (2019) · The Lancet
Lung Cancer Research StudiesCancer Immunotherapy and Biomarkers
Cited by 2,298
- Verified
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study
Kelly, W. K., Danila, D. C., Lin, C.-C., Lee, J.-L., Matsubara, N., Ward, P. J., Armstrong, A. J., Pook, D., Kim, M., Dorff, T. B., et al. (2024) · Cancer Discovery
Prostate Cancer Treatment and ResearchCancer Immunotherapy and Biomarkers
Cited by 125
- Verified
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
Powell, S. F., Gold, K. A., Gitau, M. M., Sumey, C. J., Lohr, M. M., McGraw, S. C., Nowak, R. K., Jensen, A. W., Blanchard, M. J., Fischer, C. D., et al. (2020) · Journal of Clinical Oncology
Head and Neck Cancer StudiesCancer Immunotherapy and Biomarkers
Cited by 116
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free